Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States

Natalie C. Weber, Michael E. Klepser, Julie M. Akers, Donald G Klepser, Alex J. Adams

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Review of point-of-care (POC) testing in community pharmacies, availability and specifications of CLIA-waived infectious disease POC tests, and provide recommendations for future community pharmacy POC models in an effort to improve patient outcomes while reducing antibiotic resistance. PubMed and Medscape were searched for the following keywords: infectious disease, community pharmacy, rapid diagnostic tests, rapid assay, and POC tests. All studies utilizing POC tests in community pharmacies for infectious disease were included. Studies, articles, recommendations, and posters were reviewed and information categorized into general implementation of POC testing in community pharmacies, CLIA-waived tests available, Influenza, Group A Streptococcus pharyngitis, Helicobacter pylori, HIV and Hepatitis C. POC testing provides a unique opportunity for community pharmacists to implement collaborative disease management programmes for infectious diseases and reduce over-prescribing of antibiotics and improve patient outcomes through early detection, treatment and/or referral to a specialist.

Original languageEnglish (US)
Pages (from-to)253-264
Number of pages12
JournalExpert Review of Molecular Diagnostics
Volume16
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Point-of-Care Systems
Pharmacies
Communicable Diseases
Inappropriate Prescribing
Posters
Pharyngitis
Hepatitis C
Microbial Drug Resistance
Disease Management
Streptococcus
Pharmacists
Routine Diagnostic Tests
PubMed
Helicobacter pylori
Human Influenza
Referral and Consultation
HIV
Anti-Bacterial Agents
Point-of-Care Testing

Keywords

  • CLIA-waived tests
  • HIV
  • Hepatitis C
  • Point-of-care test
  • infectious diseases
  • influenza
  • pharmacy
  • streptococcal pharyngitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States. / Weber, Natalie C.; Klepser, Michael E.; Akers, Julie M.; Klepser, Donald G; Adams, Alex J.

In: Expert Review of Molecular Diagnostics, Vol. 16, No. 2, 01.02.2016, p. 253-264.

Research output: Contribution to journalArticle

Weber, Natalie C. ; Klepser, Michael E. ; Akers, Julie M. ; Klepser, Donald G ; Adams, Alex J. / Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States. In: Expert Review of Molecular Diagnostics. 2016 ; Vol. 16, No. 2. pp. 253-264.
@article{75a1ca40207d4d4fbe185daf379d53a3,
title = "Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States",
abstract = "Review of point-of-care (POC) testing in community pharmacies, availability and specifications of CLIA-waived infectious disease POC tests, and provide recommendations for future community pharmacy POC models in an effort to improve patient outcomes while reducing antibiotic resistance. PubMed and Medscape were searched for the following keywords: infectious disease, community pharmacy, rapid diagnostic tests, rapid assay, and POC tests. All studies utilizing POC tests in community pharmacies for infectious disease were included. Studies, articles, recommendations, and posters were reviewed and information categorized into general implementation of POC testing in community pharmacies, CLIA-waived tests available, Influenza, Group A Streptococcus pharyngitis, Helicobacter pylori, HIV and Hepatitis C. POC testing provides a unique opportunity for community pharmacists to implement collaborative disease management programmes for infectious diseases and reduce over-prescribing of antibiotics and improve patient outcomes through early detection, treatment and/or referral to a specialist.",
keywords = "CLIA-waived tests, HIV, Hepatitis C, Point-of-care test, infectious diseases, influenza, pharmacy, streptococcal pharyngitis",
author = "Weber, {Natalie C.} and Klepser, {Michael E.} and Akers, {Julie M.} and Klepser, {Donald G} and Adams, {Alex J.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1586/14737159.2015.1116388",
language = "English (US)",
volume = "16",
pages = "253--264",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States

AU - Weber, Natalie C.

AU - Klepser, Michael E.

AU - Akers, Julie M.

AU - Klepser, Donald G

AU - Adams, Alex J.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Review of point-of-care (POC) testing in community pharmacies, availability and specifications of CLIA-waived infectious disease POC tests, and provide recommendations for future community pharmacy POC models in an effort to improve patient outcomes while reducing antibiotic resistance. PubMed and Medscape were searched for the following keywords: infectious disease, community pharmacy, rapid diagnostic tests, rapid assay, and POC tests. All studies utilizing POC tests in community pharmacies for infectious disease were included. Studies, articles, recommendations, and posters were reviewed and information categorized into general implementation of POC testing in community pharmacies, CLIA-waived tests available, Influenza, Group A Streptococcus pharyngitis, Helicobacter pylori, HIV and Hepatitis C. POC testing provides a unique opportunity for community pharmacists to implement collaborative disease management programmes for infectious diseases and reduce over-prescribing of antibiotics and improve patient outcomes through early detection, treatment and/or referral to a specialist.

AB - Review of point-of-care (POC) testing in community pharmacies, availability and specifications of CLIA-waived infectious disease POC tests, and provide recommendations for future community pharmacy POC models in an effort to improve patient outcomes while reducing antibiotic resistance. PubMed and Medscape were searched for the following keywords: infectious disease, community pharmacy, rapid diagnostic tests, rapid assay, and POC tests. All studies utilizing POC tests in community pharmacies for infectious disease were included. Studies, articles, recommendations, and posters were reviewed and information categorized into general implementation of POC testing in community pharmacies, CLIA-waived tests available, Influenza, Group A Streptococcus pharyngitis, Helicobacter pylori, HIV and Hepatitis C. POC testing provides a unique opportunity for community pharmacists to implement collaborative disease management programmes for infectious diseases and reduce over-prescribing of antibiotics and improve patient outcomes through early detection, treatment and/or referral to a specialist.

KW - CLIA-waived tests

KW - HIV

KW - Hepatitis C

KW - Point-of-care test

KW - infectious diseases

KW - influenza

KW - pharmacy

KW - streptococcal pharyngitis

UR - http://www.scopus.com/inward/record.url?scp=84957438999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957438999&partnerID=8YFLogxK

U2 - 10.1586/14737159.2015.1116388

DO - 10.1586/14737159.2015.1116388

M3 - Article

VL - 16

SP - 253

EP - 264

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 2

ER -